PTGS2 and isolated hemihyperplasia: A recent study conducted in a mouse model demonstrated that the blockage of the COX-2-PGE2 pathway through a specific COX-2 inhibitor (celocoxib) was able to abrogate the pro-oncogenic effects of IH.